CDK20 and cancer: In conclusion, CDK20 has a driver function in various cancer-associated pathways, and even though the mechanisms of CDK20 involvement in cancer progression are not completely elucidated, the downregulation of CDK20 in cancer has a proven therapeutic potential [146].